Trading Signals: SAGE Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)(SAGE Therapeutics Inc)
| SAGE latest price $34.2100 (-1.61%) ($34.2100 - $34.2100) on Mon. Jul. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 56 | Latest Price | $34.2100(-1.61%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SAGE advances 0.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support SAGE advance at 0% a week (0% probability) IBB(44%) IWC(38%) IWO(36%) IWM(34%) IWN(31%) | Factors Impacting SAGE price | SAGE will decline at least -2.005% in a week (0% probabilities). VIXM(-18%) UUP(-10%) UNG(-4%) VXX(-2%) TLT(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $34.65 | 5 Day Moving Average | $35.39(-3.33%) | 10 Day Moving Average | $35.22(-2.87%) | 20 Day Moving Average | $34.65(-1.27%) | To recent high | -8.9% | To recent low | 24.3% | Market Cap | $1.777b | | | | SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA. |